{"id":27,"date":"2012-03-08T20:28:24","date_gmt":"2012-03-08T11:28:24","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=27"},"modified":"2018-08-27T10:56:06","modified_gmt":"2018-08-27T01:56:06","slug":"2008paper","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=27","title":{"rendered":"2008\u5e74"},"content":{"rendered":"<ol class=\"worksUL\">\n<li class=\"number\">Ito K, Kakehi Y, Naito S, Okuyama A; Japanese Urological Association\uff1aJapanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. Int J Urol; 15:763-768, 2008.<\/li>\n<li class=\"number\">Ito K, Suzuki K, Naito S and Okuyama A\uff1aPolicy of the Japanese Urological Association on PSA-based Screening for Prostate Cancer. Japan Medical Association Journal; 51(5):327-329, 2008.<\/li>\n<li class=\"number\">Ohi M, Ito K, Yamamoto T, Miyakubo M, Takechi H, Kubota Y and Suzuki K\uff1aChanges in baseline PSA levels in Japanese men from 1988 to 2003. Urology; 72(1):95-98, 2008.<\/li>\n<li class=\"number\">Okamura K, Koike H, Matsui H and Suzuki K\uff1aGene expression profiles of prostate cancer cell lines, LNCap, PC-3 and DU-145, assessed by cDNA microarray. Kitakanto Med J; 58(4):363-369, 2008.<\/li>\n<li class=\"number\">Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H and Suzuki K\uff1aFurther evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. Int Urol Nephrol; 40(4):947-951, 2008.<\/li>\n<li class=\"number\">Koike H, Sekine Y, Kamiya M, Nakazato H and Suzuki K\uff1aGene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. Urology; 72(6):1229-1233, 2008.<\/li>\n<li class=\"number\">Hamano T, Matsui H, Ohtake N, Nakata S and Suzuki K\uff1aPolymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population. Asia-Pacific Journal of Clinical Oncology; 4(1):21-26, 2008.<\/li>\n<li class=\"number\">Takechi H, Ito K, Yamamoto T, Miyakubo M, Ohi M and Suzuki K\uff1aProstate-specific antigen kinetics in screen-detected prostate cancer in Japan. Urology; 72(5):1111-1115, 2008.<\/li>\n<li class=\"number\">Yamamoto T, Ito K, Miyakubo M, Takechi H, Suzuki K, Akimoto T, Ishikawa H and Nakano T\uff1aNomogram ranking as new objective evaluation method in various treatment stratagies for patients with prostate cancer with various clinicopathologic backgrounds. Urology; 72(4):892-897, 2008.<\/li>\n<li class=\"number\">Sekine Y, Furuya Y, Nishii M. Koike H, Matsui H and Suzuki K\uff1aSimvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Biochemical and Biophysical Research Communications; 372:356-361, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u73fe\u72b6. \u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u8a8c; 15(2):99-103, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u7b2c\uff11\u90e8\u524d\u7acb\u817a\u764c\u306e\u30ad\u30e5\u30a2\u3068\u30b1\u30a2<br \/>\n\u30b3\u30e9\u30e01\u3000PSA\u691c\u67fb\u306e\u666e\u53ca\u3067\u524d\u7acb\u817a\u764c\u6cbb\u7642\u306e\u4f55\u304c\u5909\u308f\u3063\u305f\uff1f. \u6ccc\u5c3f\u5668\u30b1\u30a2\uff62\u524d\u7acb\u817a\u764c&amp;\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u30ad\u30e5\u30a2\u3068\u30b1\u30a2\u3000\u5b8c\u5168\u30ac\u30a4\u30c9\uff63; 13(2):143-145, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u7b2c5\u7ae0\u3000\u8a3a\u7642\u306b\u95a2\u3059\u308bQ&amp;A\u30001.\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u8a3a\u7642\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u764c\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u3064\u3044\u3066\u6559\u3048\u3066\u304f\u3060\u3055\u3044. \u30d5\u30a1\u30fc\u30de\u30ca\u30d3\u30b2\u30fc\u30bf\u30b7\u30ea\u30fc\u30ba\u300e\u4e0b\u90e8\u5c3f\u8def\u6a5f\u80fd\u969c\u5bb3\u7de8\u300f\u3001\u67ff\u5d0e\u79c0\u5b8f\u30fb\u5409\u7530\u6b63\u8cb4\u7de8; pp.\u30e1\u30c7\u30a3\u30ab\u30eb\u30ec\u30d3\u30e5\u30fc\u793e\u3001\u6771\u4eac, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(\u81e8\u5897):237-241, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u2015\u8a3a\u65ad\u30fb\u6cbb\u7642\u306e\u6700\u65b0\u52d5\u5411\uff1a\u306f\u3058\u3081\u306b. \u9031\u520a\u300c\u533b\u5b66\u306e\u3042\u3086\u307f\u300d; 225(12):1211-1212, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\uff1b\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u65b0\u5c55\u958b\uff1a\u8a3a\u65ad\u306e\u65b0\u5c55\u958b\uff1aPSA\u691c\u8a3a\u306f\u306a\u305c\u5fc5\u8981\u304b. Pharma Medica; 26(8):11-14, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u300c\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u3000\u8a18\u9332\u96c6\u300d\uff1a\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u6982\u7565\u30fb\u4ed6\u306e\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068\u306e\u6bd4\u8f03. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(8):1197-1201, 2008.<\/li>\n<li class=\"number\">\u4f0a\u85e4\u4e00\u4eba\uff1a\u7279\u96c6\u300c\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u73fe\u72b6\u3068\u5c55\u671b\u300d\uff1a\u308f\u304c\u56fd\u306b\u304a\u3051\u308b\u691c\u8a3a\u4e8b\u696d\u306e\u6b74\u53f2\u3068\u73fe\u72b6. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(12):1571-1578, 2008.<\/li>\n<li class=\"number\">\u5c0f\u6c60\u79c0\u548c\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u897f\u4e95\u660c\u5f18\u3001\u66f2\u3000\u53cb\u5f18\u3001\u677e\u4e95\u3000\u535a\u3001\u5c71\u672c\u3000\u5de7\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u518d\u71c3\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u30c9\u30bb\u30bf\u30ad\u30bb\u30eb\u7642\u6cd5\u306e\u691c\u8a0e. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(8):1123-1126, 2008.<\/li>\n<li class=\"number\">\u9234\u6728\u548c\u6d69\u3001\u5927\u7af9\u4f38\u660e\u3001\u677e\u4e95\u3000\u535a\u3001\u4e2d\u7530\u8aa0\u53f8\uff1a\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u6ccc\u5c3f\u5668\u79d1\u9818\u57df\u306b\u304a\u3051\u308b\u67d3\u8272\u4f53\u7570\u5e38\u3001\u907a\u4f1d\u5b50\u75be\u60a3\u306e\u3059\u3079\u3066<br \/>\n\u60aa\u6027\u75be\u60a3\u3068\u67d3\u8272\u4f53\u7570\u5e38\u30fb\u907a\u4f1d\u5b50\u7570\u5e38\u3000\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c. Urology View; 6(5):52-55, 2008.<\/li>\n<li class=\"number\">\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u6b66\u667a\u6d69\u4e4b\u3001\u5927\u4e95\u3000\u52dd\u3001\u9234\u6728\u548c\u6d69\uff1a\u7537\u6027\u578b\u8131\u6bdb\u75c7\u7528\u85ac\u30d7\u30ed\u30da\u30b7\u30a2\u00ae\u9320\uff08\u30d5\u30a3\u30ca\u30b9\u30c6\u30ea\u30c9\uff09\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306b\u304a\u3051\u308b\u5185\u670d\u75c7\u4f8b\u3068\u5e74\u9f62\u3092\u30de\u30c3\u30c1\u3055\u305b\u305f\u975e\u5185\u670d\u75c7\u4f8b\u306e\u8840\u6e05PSA\u5024\u306e\u6bd4\u8f03. \u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u8a8c; 15:125-127, 2008.<\/li>\n<li class=\"number\">\u5c71\u672c\u3000\u5de7\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u8d64\u5009\u529f\u4e00\u90ce\uff1a\u300c\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u3000\u8a18\u9332\u96c6\u300d\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u65bd\u8a2d\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30a2\u30f3\u30b1\u30fc\u30c8\u96c6\u8a08\u5831\u544a\uff0d\u5e73\u621018\u5e74\u5ea6\uff0d. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(8):1193-1196, 2008.<\/li>\n<li class=\"number\">\u5965\u5c71\u660e\u5f66\u3001\u5185\u85e4\u8aa0\u4e8c\u3001\u4eca\u6751\u77e5\u660e\u3001\u5eb7\u6c38\u79c0\u751f\u3001\u8d64\u5ea7\u82f1\u4e4b\u3001\u6a0b\u4e4b\u6d25\u53f2\u90ce\u3001\u8352\u4e95\u967d\u4e00\u3001\u7b67\u3000\u5584\u884c\u3001\u571f\u5668\u5c4b\u5353\u5fd7\u3001\u9834\u5ddd\u3000\u664b\u3001\u9234\u6728\u548c\u6d69\u3001\u53e4\u8cc0\u5bdb\u53f2\u3001\u821b\u68ee\u76f4\u54c9\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u5ddd\u5cf6\u6e05\u9686\u3001\u6c96\u539f\u5b8f\u6cbb\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 2008\u5e74\u5ea6\u7248. \u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7de8; \u91d1\u539f\u51fa\u7248\u3001\u6771\u4eac, 2008.<\/li>\n<li class=\"number\">\u7530\u4e2d\u5553\u5e79\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5cf6\u5d0e\u3000\u6df3\uff1a\u300c\u524d\u7acb\u817a\u691c\u8a3a\u5354\u8b70\u4f1a\u904b\u55b6\u59d4\u54e1\u4f1a\u30fb\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u5408\u540c\u4f1a\u8b70\u3000\u8a18\u9332\u96c6\u300d\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u73ed\uff08\u7530\u4e2d\u73ed\uff09\u5e73\u621015\u5e74\u5ea6\u7d50\u679c\u5831\u544a. \u6ccc\u5c3f\u5668\u5916\u79d1; 21(8):1187-1192, 2008.<\/li>\n<li class=\"number\">\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u5fb3\u6c38\u3000\u5353\u3001\u5927\u4e95\u3000\u52dd\u3001\u6751\u677e\u548c\u9053\u3001\u5bcc\u7530\u3000\u5149\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\uff1a\u9ed2\u6ca2\u75c5\u9662\u9ad8\u5d0e\u5065\u5eb7\u7ba1\u7406\u30bb\u30f3\u30bf\u30fc\u4eba\u9593\u30c9\u30c3\u30af\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306b\u304a\u3051\u308b\u75ab\u5b66\u8abf\u67fb\u7814\u7a76\u3067\u306e\u540c\u610f\u53d6\u5f97\u306b\u3064\u3044\u3066(\u7b2c\uff12\u5831). \u7fa4\u99ac\u533b\u5b66; 87:231-234, 2008.<\/li>\n<li class=\"number\">\u5468\u6771\u5b5d\u6d69\u3001\u5897\u7530\u3000\u5e83\u3001\u5927\u7af9\u4f38\u660e\u3001\u5927\u77f3\u7422\u78e8\u3001\u95a2\u539f\u54f2\u592b\uff1a\u8180\u80f1\u30bf\u30f3\u30dd\u30ca\u30fc\u30c7\u3092\u5951\u6a5f\u3068\u3057\u305f\u98df\u9053\u764c\u524d\u7acb\u817a\u8ee2\u79fb. \u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d1; 62(9):709-711, 2008.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Ito K, Kakehi Y, Naito S, Okuyama A; Japanese Urological Association\uff1aJapanese Urological Association guideline [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-27","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/27","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27"}],"version-history":[{"count":1,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/27\/revisions"}],"predecessor-version":[{"id":1304,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/27\/revisions\/1304"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}